- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
UFDI Investigator Desmond Schatz, MD
Medical Director of the UF Diabetes Institute and past president of medicine and science of the American Diabetes Association (ADA) is the senior author of the ADA’s (…)
Read More
TrialNet ATG-GCSF New Onset Study
UF researchers publish 2 year findings testing a combination therapy for people with newly diagnosed type 1 diabetes
Read More
UFDI Investigator Desmond Schatz, MD
1
TrialNet ATG-GCSF New Onset Study
2
The Hydroxycloroquine Prevention Study
3
UFDI Investigator Desmond Schatz, MD
Medical Director of the UF Diabetes Institute and past president of medicine and science of the American Diabetes Association (ADA) is the senior author of the ADA’s (…)
TrialNet ATG-GCSF New Onset Study
UF researchers publish 2 year findings testing a combination therapy for people with newly diagnosed type 1 diabetes
TuDiabetes Live Interview with Dr. Michael Haller, TrialNet ATG-GCSF New Onset Study
